MULTIPHARMACY LTD.
Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (83/100, director aged 66). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (77/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-02-28 | 2024-02-29 |
|---|---|---|
| Total assets | £10 | £10 |
| Cash | £10 | £10 |
| Net assets | £10 | £10 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
Corporate timeline (22 events)Click to expand
- 2025-11-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-11-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-08-17📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-04-28📄accounts-with-accounts-type-dormantaccounts · AA
- 2021-03-12📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-06-05📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-04-12📄accounts-with-accounts-type-dormantaccounts · AA
- 2018-06-04📄accounts-with-accounts-type-dormantaccounts · AA
- 2017-10-20📄accounts-with-accounts-type-dormantaccounts · AA
- 2016-11-07📄accounts-with-accounts-type-dormantaccounts · AA
- 2015-10-29📄accounts-with-accounts-type-dormantaccounts · AA
- 2015-08-19📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-11-21📄accounts-with-accounts-type-dormantaccounts · AA
- 2014-08-28📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2013-11-22📄accounts-with-accounts-type-dormantaccounts · AA
- 2005-08-15🏢Company incorporatedAs MULTIPHARMACY LTD.
- 2005-08-15➕JANDOO, Satwant Kaur appointedsecretary
- 2005-08-15➕JANDOO, Virinder Singh appointeddirector
- 2005-08-15➕BRIAN REID LTD. appointedcorporate-nominee-secretary
- 2005-08-15➖BRIAN REID LTD. resignedcorporate-nominee-secretary
- 2005-08-15➕STEPHEN MABBOTT LTD. appointedcorporate-nominee-director
- 2005-08-15➖STEPHEN MABBOTT LTD. resignedcorporate-nominee-director
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 21 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 66 — succession pressure is live.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 63+: Senior director is approximately 66. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- primary20+ year tenure: Director in role 21 years. Very long tenure is a classic succession signal.
- secondaryStable-but-static management: Company is 21 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanGroup structure
Park Road Pharmacy Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Park Road Pharmacy Limited Corporate entity | 75–100% | — | 75-100% shares | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Retail · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| PAY YOUR WAY CARPETS LIMITED→ SC852229 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| PEDLAR LTD→ SC724245 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| PETER STORE LTD→ SC630634 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| PHS TRADING LTD→ SC871515 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| PI DRUM SHOP LIMITED→ SC595912 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| PILLAR AND SABLE LTD→ SC854853 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| PINK POODLE LIMITED→ SC237375 · est 2002 · no financials extracted | — | — | — | — | 23y | — | — |
| PLECOMM LTD→ SC868602 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| PLUSH LINEN LTD→ SC810222 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| POUNDLY LTD→ SC869028 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| POWDIFY LTD→ SC818503 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| PRATAP BROTHERS ECOMM LIMITED→ SC882261 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 2 resigned)
Click a director name to see their full track record across all companies.